Skip to content
  • Clinical Studies
  • Pharma SOP’s
  • Pharma tips
  • Pharma Books
  • Stability Studies
  • Schedule M

Pharma GMP

Your Gateway to GMP Compliance and Pharmaceutical Excellence

  • Home
  • Quick Guide
  • GMP Failures & Pharma Compliance
    • Common GMP Failures
    • GMP Documentation & Records Failures
    • Cleaning & Sanitation Failures in GMP Audits
    • HVAC, Environmental Monitoring & Cross-Contamination Risks
  • Toggle search form

SOP for Issuance and Control of GMP Logbooks

Posted on November 25, 2025 By digi


SOP for Issuance and Control of GMP Logbooks

Standard Operating Procedure for Controlled Issuance and Management of GMP Logbooks

In pharmaceutical manufacturing, maintaining strict control over documentation is essential to comply with GMP regulations and ensure data integrity. Logbooks are critical tools used across Quality Assurance (QA), Production, QC, and other departments to record batch activities, equipment usage, cleaning validation, environmental monitoring, and more. A rigorous logbook control SOP establishes a traceable, authorized process for the issuance, numbering, use, and closure of all GMP logbooks. Such control mitigates risk of data loss, unauthorized entries, and regulatory non-compliance, supporting inspection readiness across FDA, EMA, MHRA, PIC/S, and WHO-regulated operations in the US, UK, and EU.

Step 1: Scope and Purpose of the Logbook Control SOP

The foundation of any logbook control SOP is a clearly defined scope and purpose. This section ensures all stakeholders—from QA to manufacturing line operators—understand the intent and applicability of the procedure.

  • Scope: This SOP applies to all GMP logbooks used within the manufacturing facility and associated departments involved in pharmaceutical production and quality management.
  • Purpose: The SOP aims to:
    • Control the issuance of blank GMP logbooks to authorized users.
    • Maintain accurate numbering and traceability through an issue-register.
    • Ensure standard practices for active use, corrections, and data entries in logbooks.
    • Define the closure process for completed or obsolete logbooks.
    • Support compliance with applicable GMP guidelines including FDA 21 CFR Part 211, EU GMP (Volume 4), and PIC/S recommendations.

Clarifying these aspects directs consistent operational practice and establishes a quality framework that is auditable and repeatable across all departments.

Step 2: Responsibilities and Authorization for Logbook Control

Every effective SOP delineates responsibilities for key roles. A robust logbook control SOP assigns accountability for the logbook lifecycle to ensure no uncontrolled issuance or loss of documentation occurs.

  • Quality Assurance (QA) Manager or Document Control: Overall ownership of the logbook system, maintenance of the issue-register, and periodic review of logbook control effectiveness.
  • Logbook Custodian: A designated individual, often within QA or production, authorized to issue, receive, and archive logbooks per the SOP.
  • Users (Operators, Analysts, Engineers): Responsible for proper use of issued logbooks, timely and accurate entries, and reporting damaged or lost logbooks immediately.
  • Supervisors/Heads of Departments: Approval for issuance requests, and monitoring compliance within their team.
Also Read:  SOP for Calibration of Production Equipment and Critical Instruments

Creating a clear delegation of authority eliminates ambiguity, ensuring compliance with regulatory expectations and preventing potential deviations due to mishandling or misplacement of logbooks.

Step 3: Establishing the Logbook Numbering System

A systematic numbering scheme is fundamental for tracking and traceability of logbooks throughout their lifecycle. This structure prevents duplication, misplacement, and unauthorized use.

  • Format Example: A typical numbering system may include segments to identify the facility, department, logbook type, and unique sequential number—for example, FAC-PRD-LOG-00123, where:
    • FAC = Facility code (e.g., main plant)
    • PRD = Department code (Production)
    • LOG = Indicates logbook
    • 00123 = Sequential serial number
  • Number Allocation: Numbers must be assigned sequentially without gaps to facilitate inventory management and ease audit trail verification.
  • Registration: Each newly issued logbook number is recorded in the issue-register along with issuance details (date, user, purpose).

Such numbering schemes align with various global GMP documentation requirements emphasizing traceability through uniquely identified controlled documents as per [EMA’s Guidelines on Documentation](https://ec.europa.eu/health/sites/default/files/files/eudralex/vol-4/2014_11_annex11_good_manuf_practice.pdf).

Step 4: Logbook Request, Issuance, and Issue-Register Maintenance

The issuance procedure must be tightly controlled to ensure logbooks are provided only to authorized personnel and tracked precisely. This step details the standard methodology:

  • Request Submission: Users requiring a new logbook submit a formal request to the Logbook Custodian or QA, specifying intended use, department, and required quantity.
  • Approval: Supervisors or Department Heads review and approve the request based on actual operational need and logbook availability.
  • Issuance: The Logbook Custodian issues the logbook(s), annotates the unique number(s) against the user and issuance date in the issue-register, and provides the user with instructions on handling and usage.
  • Issue-Register Documentation: The register must include at minimum:
    • Logbook number
    • Date of issuance
    • Requester name and department
    • Purpose of use
    • Signature of custodian and recipient
  • Stock Control: Maintain physical inventory and reorder levels to prevent shortages or overstocking.
Also Read:  SOP for GxP Computerized System Validation and Change Control

Maintaining a detailed and contemporaneous issue-register is essential to prevent unauthorized or lost logbooks, meeting data integrity principles under [FDA 21 CFR Part 211](https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211).

Step 5: Usage, Entries, and Data Integrity in GMP Logbooks

Proper use and data integrity in logbooks are critical for regulatory compliance and operational transparency.

  • Entries: All entries must be made in indelible ink, dated, and signed with the full name and designation.
  • Corrections: Corrections may only be made by striking through the incorrect information with a single line, adding the correct entry alongside, and initialing with date. Erasures or use of correction fluid are prohibited.
  • Legibility and Completeness: Entries should be legible, unambiguous, and made contemporaneously.
  • Logbook Use Restrictions: Logbooks must only be used for their intended purpose and by authorized personnel. Transfer of logbooks between different departments or personnel requires approval and documentation.
  • Handling of Damage or Loss: Immediately report any lost, damaged, or defaced logbooks to QA. Investigations and mitigation actions should be implemented as required.

Adhering to good documentation practices and data integrity principles in logbook handling aligns with international standards such as [PIC/S GMP Guide PE 009-13](https://picscheme.org/docview/30) and ensures readiness for inspections and audits.

Step 6: Closure, Archival, and Retention of GMP Logbooks

Once a logbook is fully used or the relevant operational period is complete, formal closure and proper archival must be performed to maintain control and enable retrieval during inspections or investigations.

  • Closure: The user must affix a closure page at the end of the logbook summarizing:
    • Final entry date
    • Total number of pages used
    • Signature and date of the user and supervisor
  • Return to Custodian: The closed logbook is returned to the Logbook Custodian, who verifies the closure and updates the issue-register with the return date and condition of the logbook.
  • Archival: Logbooks are archived in a controlled environment meeting secure storage requirements (e.g., controlled temperature, restricted access).
  • Retention Period: The retention time must comply with applicable regulatory requirements, typically a minimum of one year after the expiry date of the related batch or as specified by the Quality Risk Management strategy.
  • Disposition: After the retention period, destruction or permanent archiving processes must be approved and documented by QA.
Also Read:  Designing SOPs for Cleaning Non-Product Contact Areas

Following established closure and archiving procedures ensures traceability for retrospective review and audit trails, consistent with [EU GMP Annex 15 on Qualification and Validation](https://ec.europa.eu/health/sites/default/files/files/eudralex/vol-4/2015_06_annex15.pdf).

Step 7: Periodic Review and Continuous Improvement

Logbook management is an evolving process that benefits from continuous monitoring and improvement to address emerging regulatory requirements and operational challenges.

  • Periodic Audits: QA should conduct scheduled audits of logbook control procedures, including verification of the issue-register, traceability, closure records, and adherence to data integrity practices.
  • Training and Awareness: Regular training for all logbook users and custodians on updated SOPs, documentation standards, and inspection expectations.
  • Deviation Management: Any non-compliances or deviations identified during audits or daily operations must be logged, investigated, and corrective/preventive actions implemented.
  • SOP Updates: Periodic review and revision of the logbook control SOP ensure alignment with latest regulatory guidelines and organizational policies.

Continuous evaluation guarantees that the logbook control system remains robust and inspection-ready, fostering confidence in data reliability and regulatory compliance across the organization.

Summary and Best Practices for Effective Logbook Control SOP Implementation

Implementing a thorough and compliant logbook control SOP is vital for pharmaceutical manufacturers operating under stringent regulatory frameworks such as FDA, EMA, MHRA, PIC/S, and WHO GMP. The key aspects can be summarized as:

  • Define clear scope, purpose, and roles for ownership of logbook control.
  • Establish a logical, unambiguous numbering system to uniquely identify each logbook.
  • Maintain a comprehensive and updated issue-register documenting issuance and return of logbooks.
  • Enforce strict data integrity principles during logbook use, including proper corrections and timely entries.
  • Outline precise closure procedures, ensuring traceability of completed logbooks with proper archival and retention.
  • Drive continuous improvement through audits, training, and regular SOP reviews.

By following this step-by-step tutorial guide, pharmaceutical QA and operational teams can establish a reliable documentation control system that supports GMP compliance, facilitates inspection readiness, and safeguards data integrity across all GMP logbook applications.

Logbooks Tags:closure, issuance, logbooks, pharmasop, sop

Post navigation

Previous Post: SOP for Preventive Maintenance of Manufacturing Equipment
Next Post: SOP for Audit Trail Review of Computerized Systems

Quick Guide

  • GMP Basics
    • Introduction to GMP
    • What is cGMP?
    • Key Principles of GMP
    • Benefits of GMP in Pharmaceuticals
    • GMP vs. GxP (Good Practices)
  • Regulatory Agencies & Guidelines
    • WHO GMP Guidelines
    • FDA GMP Guidelines
    • MHRA GMP Guidelines
    • SCHEDULE – M – Revised
    • TGA GMP Guidelines
    • Health Canada GMP Regulations
    • NMPA GMP Guidelines
    • PMDA GMP Guidelines
    • EMA GMP Guidelines
  • GMP Compliance & Audits
    • How to Achieve GMP Certification
    • GMP Auditing Process
    • Preparing for GMP Inspections
    • Common GMP Violations
    • Role of Quality Assurance
  • Quality Management Systems (QMS)
    • Building a Pharmaceutical QMS
    • Implementing QMS in Pharma Manufacturing
    • CAPA (Corrective and Preventive Actions) for GMP
    • QMS Software for Pharma
    • Importance of Documentation in QMS
    • Integrating GMP with QMS
  • Pharmaceutical Manufacturing
    • GMP in Drug Manufacturing
    • GMP for Biopharmaceuticals
    • GMP for Sterile Products
    • GMP for Packaging and Labeling
    • Equipment and Facility Requirements under GMP
    • Validation and Qualification Processes in GMP
  • GMP Best Practices
    • Total Quality Management (TQM) in GMP
    • Continuous Improvement in GMP
    • Preventing Cross-Contamination in Pharma
    • GMP in Supply Chain Management
    • Lean Manufacturing and GMP
    • Risk Management in GMP
  • Regulatory Compliance in Different Regions
    • GMP in North America (FDA, Health Canada)
    • GMP in Europe (EMA, MHRA)
    • GMP in Asia (PMDA, NMPA, KFDA)
    • GMP in Emerging Markets (GCC, Latin America, Africa)
    • GMP in India
  • GMP for Small & Medium Pharma Companies
    • Implementing GMP in Small Pharma Businesses
    • Challenges in GMP Compliance for SMEs
    • Cost-effective GMP Compliance Solutions for Small Pharma Companies
  • GMP in Clinical Trials
    • GMP Compliance for Clinical Trials
    • Role of GMP in Drug Development
    • GMP for Investigational Medicinal Products (IMPs)
  • International GMP Inspection Standards and Harmonization
    • Global GMP Inspection Frameworks
    • WHO Prequalification and Inspection Systems
    • US FDA GMP Inspection Programs
    • EMA and EU GMP Inspection Practices
    • PIC/S Role in Harmonized Inspections
    • Country-Specific Inspection Standards (e.g., UK MHRA, US FDA, TGA)
  • GMP Blog

Latest Posts

  • GMP-cGMP Regulations & Global Standards
    • FDA cGMP Regulations for Drugs & Biologics
    • cGMP Requirements for Pharmaceutical Manufacturers
    • ICH Q7 and API GMP Expectations
    • Global & ISO-Based GMP Standards
    • GMP for Medical Devices & Combination Products
    • GMP for Pharmacies & Hospital Pharmacy Settings
  • Applied GMP in Pharma Manufacturing & Operations
    • GMP for Pharmaceutical Drug Product Manufacturing
    • GMP for Biotech & Biologics Manufacturing
    • GMP Documentation
    • GMP Compliance
    • GMP for APIs & Bulk Drugs
    • GMP Training
  • Computer System Validation (CSV) & GxP Computerized Systems
    • CSV Fundamentals in Pharma & Biotech
    • FDA CSV Guidance & 21 CFR Part 11 Alignment
    • GAMP 5 & Risk-Based Validation Approaches
    • CSV in Pharmaceutical & GxP Industries (Use-Cases & System Types)
    • CSV Documentation
    • CSV for Regulated Equipment & Embedded Systems
  • Data Integrity & 21 CFR Part 11 Compliance
    • Data Integrity Principles in cGMP Environments
    • FDA Data Integrity Guidance & Expectations
    • 21 CFR Part 11 – Electronic Records & Signatures
    • Data Integrity in GxP Computerized Systems
    • Data Integrity Audits
  • Pharma GMP & Good Manufacturing Practice
    • FDA 483, Warning Letters & GMP Inspections
    • Data Integrity, ALCOA+ & Part 11 / Annex 11
    • Process Validation, CPV & Cleaning Validation
    • Contamination Control & Annex 1
    • PQS / QMS / Deviations / CAPA / OOS–OOT
    • Documentation, Batch Records & GDP
    • Sterility, Microbiology & Utilities
    • CSV, GAMP 5 & Automation
    • Dosage-Form–Specific GMP (Solids, Liquids, Sterile, Topicals)
    • Supply Chain, Warehousing, Cold Chain & GDP
Widget Image
  • Never Assign Batch Release Responsibilities to Non-QA Personnel in GMP

    Never Assign Batch Release Responsibilities… Read more

  • Manufacturing & Batch Control
    • GMP manufacturing process control
    • Batch Manufacturing record requirements
    • Master Batch record template for pharmaceuticals
    • In Process control checks in tablet manufacturing
    • Line clearance procedure before batch start
    • Batch reconciliation in pharmaceutical manufacturing
    • Yield reconciliation GMP guidelines
    • Segregation of different strength products GMP
    • GMP controls for high potency products
    • Cross Contamination prevention in manufacturing
    • Line clearance checklist for production
    • Batch documentation review before qa release
    • Process parameters control limits in pharma
    • Equipment changeover procedure GMP
    • Batch manufacturing deviation handling
    • GMP expectations for batch release
    • In Process sampling plan for tablets
    • Visual inspection of dosage forms GMP requirements
    • In Process checks for filled vials
    • Startup and Shutdown procedure for manufacturing line
    • GMP requirements for blending and mixing operations
    • Process Control strategy in pharmaceutical manufacturing
    • Uniformity of dosage units in process controls
    • GMP checklist for oral solid dosage manufacturing
    • Process Control
    • Batch Documentation
    • Master Batch Records
    • In-Process Controls
    • Line Clearance
    • Yield & Reconciliation
    • Segregation & Mix-Ups
    • High Potency Products
    • Cross Contamination Control
    • Line Clearance
    • Batch Review
    • Process Parameters
    • Equipment Changeover
    • Deviations
    • Batch Release
    • In-Process Sampling
    • Visual Inspection
    • In-Process Checks for Vials
    • Start-Up & Shutdown
    • Blending & Mixing
    • Control Strategy
    • Dosage Uniformity
    • Hold Time Studies
    • OSD GMP Checklist
  • Cleaning & Contamination Control
  • Warehouse & Material Handling
    • Warehouse GMP
    • Material Receipt
    • Sampling
    • Status Labelling
    • Storage Conditions
    • Rejected & Returned
    • Reconciliation
    • Controlled Drugs
    • Dispensing
    • FIFO & FEFO
    • Cold Chain
    • Segregation
    • Pest Control
    • Env Monitoring
    • Palletization
    • Damaged Containers
    • Stock Verification
    • Sampling & Weighing Areas
    • Issue to Production
    • Traceability
    • Printed Materials
    • Intermediates
    • Cleaning & Housekeeping
    • Status Tags
    • Warehouse Audit
  • QC Laboratory & Testing
    • Analytical Method Validation
    • Chromatography Systems
    • Dissolution Testing
    • Assay & CU
    • Impurity Profiling
    • Stability & QC
    • OOS Investigations
    • OOT Trending
    • Sample Management
    • Reference Standards
    • Equipment Calibration
    • Instrument Qualification
    • LIMS & Electronic Data
    • Data Integrity
    • Microbiology QC
    • Sterility & Endotoxin
    • Environmental Monitoring
    • QC Documentation
    • Results Review
    • Method Transfer
    • Forced Degradation
    • Compendial Methods
    • Cleaning Verification
    • QC Deviations & CAPA
    • QC Lab Audits
  • Manufacturing & In-Process Control
    • Batch Manufacturing Records
    • Batch Manufacturing Records
    • Line Clearance
    • In-Process Sampling & Testing
    • Yield & Reconciliation
    • Granulation Controls
    • Blending & Mixing
    • Tablet Compression Controls
    • Capsule Filling Controls
    • Coating Process Controls
    • Sterile & Aseptic Processing
    • Filtration & Sterile Filtration
    • Visual Inspection of Parenteral
    • Packaging & Labelling Controls
    • Rework & Reprocessing
    • Hold Time for Bulk & Intermediates
    • Manufacturing Deviations & CAPA
  • Documentation, Training & QMS
    • SOP & Documentation Control
    • Training & Competency Management
    • Change Control & QMS Lifecycle
    • Internal Audits & Self-Inspection
    • Quality Metrics, Risk & Management Review
  • Production SOPs
  • QC Laboratory SOPs
    • Sample Management
    • Analytical Methods
    • HPLC & Chromatography
    • OOS & OOT
    • Data Integrity
    • Documentation
    • Equipment
  • Warehouse & Materials SOPs
    • Material Receipt
    • Sampling
    • Storage
    • Dispensing
    • Rejected & Returned
    • Cold Chain
    • Stock Control
    • Printed Materials
    • Pest & Housekeeping
  • Cleaning & Sanitization SOPs
  • Equipment & Qualification SOPs
  • Documentation & Data Integrity SOPs
  • Deviation/OOS/CAPA SOPs
    • Deviation Management
    • Root Cause
    • CAPA
    • OOS/OOT
    • Complaints
    • Recall
  • Training & Competency SOPs
    • Training System
    • Role-Based Training
    • OJT
    • Refresher Training
    • Competency
  • QA & QMS Governance SOPs
    • Quality Manual
    • Management Review
    • Internal Audit
    • Risk Management
    • Vendors & Outsourcing
  • About Us
  • Privacy Policy & Disclaimer
  • Contact Us

Copyright © 2025 Pharma GMP.

Powered by PressBook WordPress theme